berk-novelwayto-2020.pdf (151.34 kB)
A novel way to quantify schizophrenia symptoms in clinical trials
journal contribution
posted on 2021-03-01, 00:00 authored by Oleg N Medvedev, Michael BerkMichael Berk, Olivia DeanOlivia Dean, Ellie Brown, Margaret H Sandham, Joanna F Dipnall, Robert K McNamara, Alexander Sumich, Christian U Krägeloh, Ajit Narayanan, Richard J SiegertA novel way to quantify schizophrenia symptoms in clinical trials
History
Journal
European journal of clinical investigationVolume
51Issue
3Article number
e13398Pagination
1 - 8Publisher
WileyLocation
Chichester, Eng.Publisher DOI
Link to full text
ISSN
0014-2972eISSN
1365-2362Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Clinical TrialGeneralisability TheoryMeasurementPositive and Negative Syndrome ScaleSchizophreniaScience & TechnologyLife Sciences & BiomedicineMedicine, General & InternalMedicine, Research & ExperimentalGeneral & Internal MedicineResearch & Experimental Medicinegeneralizability theoryNEGATIVE-SYNDROME-SCALEPANSSTRANSIENTMETAANALYSISVALIDATIONIMPACTTIME
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC